Sort
65,743 grants matching “single cell sequencing”
A Human Antibody as an Immunotherapy for Cocaine Abuse
$911,120Andrew B Norman · P2d, Inc. · R44 · FY2007 · DA
CELL EXPANSION BIOREACTORS FOR ASSAY-READY IMMUNOCOMPETENT PATIENT MODELS
$911,110Kacey Ronaldson · Link Biosystems Inc. · R44 · FY2025 · CA
Investigation into the activation of multiple bnAb precursors using structure-designed immunogens and Ig knock-in mice
$910,966Daniel Kulp · Wistar Institute · R01 · FY2024 · AI
A protease-deficient, low mutation rate E. coli for biotherapeutics production
$910,959Frederick R Blattner · Scarab Genomics, Llc · R44 · FY2013 · GM
BBSRC-NSF/BIO: Regulatory control of the system-wide innate immune response in marine invertebrates
$910,860Katherine M Buckley · Auburn University · · FY2022 · BIO
Autoimmune Stem-like CD8 T cells in Type 1 Diabetes
$910,690Andrea Schietinger · Sloan-Kettering Inst Can Research · R01 · FY2023 · AI
Mali International Center for Excellence in Research: Malaria immunology
$910,590Susan Pierce · National Institute Of Allergy And Infectious Diseases · ZIA · FY2018 · AI
Pathomic Predictors of Prostate Cancer Progression
$910,446Parag Kumar Mallick · Stanford University · R01 · FY2020 · CA
Exploring Precision Oncology: From Gene Fusions to lncRNAs
$910,078Arul M Chinnaiyan · University Of Michigan At Ann Arbor · R35 · FY2022 · CA
Exploring Precision Oncology: From Gene Fusions to lncRNAs
$910,078Arul M Chinnaiyan · University Of Michigan At Ann Arbor · R35 · FY2023 · CA
Transcriptional Regulation of Gene Expression
$909,603Alan G Hinnebusch · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2010 · HD
Project 3 (BNI)-Cholinergic alteration in mild cognitive impairment
$909,577Elliott Jay Mufson · St. Joseph'S Hospital And Medical Center · P01 · FY2020 · AG
Understanding the Cardiac Benefits of Exercise at the Cellular and Molecular Level
$909,471Anthony Rosenzweig · Massachusetts General Hospital · R35 · FY2021 · HL
Understanding the Cardiac Benefits of Exercise at the Cellular and Molecular Level
$909,471Anthony Rosenzweig · Massachusetts General Hospital · R35 · FY2022 · HL
Development and Production of Standardized Reference Diets for Zebrafish Research
$909,318Donald Corace · Meridian Biotech, Llc · R42 · FY2024 · OD
Enhanced latency reversal and reservoir clearance in macaques
$909,248Ann M Chahroudi · Emory University · R37 · FY2024 · AI
Initiation of Diffuse and Intestinal Non-Cardia Gastric Cancer
$908,985Sandra W Ryeom · Columbia University Health Sciences · R01 · FY2023 · CA
Early intervention with anti-proliferative therapy close to ART initiation to limit long-term SIV persistence
$908,973Joshua Tisdell Schiffer · Fred Hutchinson Cancer Center · R56 · FY2023 · AI
Development of a rapid response nucleic acid vaccine strategy for coronavirusepidemics
$908,934Kenneth C Bagley · Orlance, Inc. · R44 · FY2020 · AI
Laboratory And Preclinical Studies Of Flaviviruses
$908,864Stephen Whitehead · National Institute Of Allergy And Infectious Diseases · ZIA · FY2018 · AI
Statistical Methods for Analysis of Massive Genetic and Genomic Data in Cancer Research
$908,788Xihong Lin · Harvard School Of Public Health · R35 · FY2023 · CA
Nervous System Development and Plasticity
$908,732Richard Douglas Fields · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2016 · HD
High throughput CAR-T potency assay based on functional and transcriptional measurements on single cell co-cultures
$908,687Benjamin Biron Yellen · Celldom, Inc. · R44 · FY2025 · CA
COVID-19: Predictive Immune and Airway Monitoring in Healthcare workers and Hospitalized COVID-19 patients
$908,615National Institute Of Allergy And Infectious Diseases · Y01 · FY2021 · AI
Towards targeting the lymphoma microenvironment
$908,577Hans-Guido Wendel · Sloan-Kettering Inst Can Research · R35 · FY2023 · CA